You are viewing the comprehensive archive for articles tagged with "eli lilly". Our editorial team provides essential coverage, in-depth analysis, and real-time market data across all critical topics impacting the global economy. This section compiles the most relevant news, research, and expert commentary to help you navigate the trends and forces shaping the financial world. Stay informed with MarketSpeaker to ensure your knowledge is current and comprehensive.
Eli Lilly will pay up to $2.75 billion to bring AI-developed drugs from Insilico Medicine to market. The deal highlights growing momentum in AI-driven drug discovery.
Eli Lilly crossed a $1 trillion market capitalization for the first time, powered by booming demand for its diabetes and weight-loss drugs.